Moore Lee E, Smith Allan H, Eng Clarence, Kalman David, DeVries Sandy, Bhargava Vivek, Chew Karen, Moore Dan, Ferreccio Catterina, Rey Omar A, Waldman Frederic M
L. E. Moore, A. H. Smith, University of California at Berkeley School of Public Health, Berkeley, USA.
J Natl Cancer Inst. 2002 Nov 20;94(22):1688-96. doi: 10.1093/jnci/94.22.1688.
Previous studies have demonstrated that ingestion of arsenic in drinking water is a strong risk factor for several forms of cancer, including bladder cancer. It is not known whether arsenic-related cancers are genetically similar to cancers in unexposed individuals or what mechanisms of carcinogenesis may underlie their formation. This study was designed to compare chromosomal alterations in bladder cancers of arsenic-exposed individuals to provide insight into the mechanism of how arsenic may induce or promote cancer.
A case-case study was conducted in Argentina and Chile examining chromosomal alterations in bladder tumor DNA in 123 patients who had been exposed to arsenic in their drinking water. Patients were placed into one of four arsenic exposure categories according to their average 5-year peak arsenic exposure. Patients were also classified as ever smokers or never smokers. Comparative genomic hybridization was used to identify chromosomal alterations throughout the genome. All statistical tests were two-sided.
The total number of chromosomal alterations was higher in individuals exposed to higher arsenic levels (5.7 +/- 5.1, 5.6 +/- 5.1, 7.3 +/- 7.4, and 9.1 +/- 6.5 [mean +/- standard deviation] chromosomal alterations per tumor with increasing arsenic exposure; P(trend) =.02, adjusted for stage and grade). The trend was stronger in high-grade (G2-G3) tumors (6.3 +/- 5.5, 8.3 +/- 4.7, 10.3 +/- 7.8, and 10.5 +/- 6.4 alterations per tumor; P(trend) =.01) than it was in low-grade (G1) tumors (3.5 +/- 3.1, 1.1 +/- 1.1, 2.5 +/- 2.5, and 3.6 +/- 3.2 alterations per tumor; P(trend) =.79). The mean number of chromosomal alterations also increased with tumor stage and grade (P(trend)<.001) independently of arsenic exposure but was not associated with smoking history. Deletion of part or all of chromosome 17p (P(trend)<.001) showed the strongest association with arsenic exposure.
Bladder tumors in patients with higher levels of arsenic exposure showed higher levels of chromosomal instability. Most of the chromosomal alterations associated with arsenic exposure were also associated with tumor stage and grade, raising the possibility that bladder tumors from arsenic-exposed patients may behave more aggressively than tumors from unexposed patients.
先前的研究表明,饮用水中摄入砷是包括膀胱癌在内的多种癌症的重要危险因素。尚不清楚与砷相关的癌症在基因上是否与未接触砷个体的癌症相似,以及其致癌机制可能是什么。本研究旨在比较接触砷个体膀胱癌中的染色体改变,以深入了解砷可能诱发或促进癌症的机制。
在阿根廷和智利进行了一项病例对照研究,检测了123名饮用水中接触过砷的患者膀胱肿瘤DNA中的染色体改变。根据患者5年平均最高砷暴露量,将其分为四个砷暴露类别之一。患者还被分为曾经吸烟者或从不吸烟者。采用比较基因组杂交技术识别全基因组的染色体改变。所有统计检验均为双侧检验。
砷暴露水平较高的个体染色体改变总数更高(随着砷暴露增加,每个肿瘤的染色体改变数分别为5.7±5.1、5.6±5.1、7.3±7.4和9.1±6.5[平均值±标准差];经分期和分级调整后,P趋势=.02)。在高级别(G2 - G3)肿瘤中这种趋势更强(每个肿瘤的改变数分别为6.3±5.5、8.3±4.7、10.3±7.8和10.5±6.4;P趋势=.01),而在低级别(G1)肿瘤中则较弱(每个肿瘤的改变数分别为3.5±3.1、1.1±1.1、2.5±2.5和3.6±3.2;P趋势=.79)。染色体改变的平均数也随肿瘤分期和分级增加(P趋势<.001),与砷暴露无关,但与吸烟史无关。17号染色体短臂部分或全部缺失(P趋势<.001)与砷暴露的关联最强。
砷暴露水平较高患者的膀胱肿瘤显示出更高水平的染色体不稳定性。大多数与砷暴露相关的染色体改变也与肿瘤分期和分级相关,这增加了砷暴露患者的膀胱肿瘤可能比未暴露患者的肿瘤侵袭性更强的可能性。